JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB23

Anti-CD45RO antibody [UCHL1]

5

(3 Reviews)

|

(29 Publications)

Anti-CD45RO antibody [UCH-L1] (ab23) is a mouse monoclonal antibody detecting CD45RO in Western Blot, Flow Cytometry, IHC-P. Suitable for Human.

- Over 20 publications
- Trusted since 2002

View Alternative Names

CD45, PTPRC, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, L-CA

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45RO antibody [UCHL1] (AB23)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45RO antibody [UCHL1] (AB23)

ab23 (1 μg/ml) staining CD45RO in human tonsil.
Sections were stained using an automated system (DAKO Autostainer Plus ), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers citrate pH 6.1. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with hematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Western blot - Anti-CD45RO antibody [UCHL1] (AB23)
  • WB

Unknown

Western blot - Anti-CD45RO antibody [UCHL1] (AB23)

CD45RO contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.

All lanes:

Western blot - Anti-CD45RO antibody [UCHL1] (ab23) at 5 µg/mL

Lane 1:

Human tonsil normal tissue lysate - total protein (<a href='/en-us/products/unavailable/human-tonsil-normal-tissue-lysate-total-protein-ab29615'>ab29615</a>) at 20 µg

Lane 2:

Human thymus tissue lysate - total protein (<a href='/en-us/products/unavailable/human-thymus-tissue-lysate-total-protein-ab30146'>ab30146</a>) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/5000 dilution

Predicted band size: 147 kDa

Observed band size: 180 kDa

true

Exposure time: 8min

  • 660 APC

    APC Anti-CD45R0 antibody [UCHL1]

  • 519 FITC

    FITC Anti-CD45R0 antibody [UCHL1]

  • 578 PE

    PE Anti-CD45R0 antibody [UCHL1]

  • 387 mFluor™ UV375

    mFluor™ UV375 Anti-CD45RO antibody [UCHL1]

  • 454 mFluor™ Violet 450

    mFluor™ Violet 450 Anti-CD45RO antibody [UCHL1]

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

UCHL1

Isotype

IgG2a

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P, Flow Cyt

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "5 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-CD45RO antibody [UCH-L1] (ab23) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of CD45RO?
Anti-CD45RO [UCH-L1] (ab23) specifically detects a band for CD45RO (UniProt: P08575) at a molecular weight of 131kDa.

Trusted by the scientific community
Anti-CD45RO [UCH-L1] (ab23) was first used in a scientific publication in 2002 and has been cited over 20 times in peer-reviewed journals.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.02% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD45RO also known as leukocyte common antigen 2 is an important isoform of the protein tyrosine phosphatase receptor type C (PTPRC). This protein has a molecular mass of about 180 kDa. Researchers find CD45RO expressed mostly on memory T cells a subset of T lymphocytes. These cells play an essential role in the immune system by remembering past infections or vaccinations. CD45RO functions mechanistically by modulating T cell receptor (TCR) signaling which is important for antibody production.
Biological function summary

This isoform plays an important role in immune responses by supporting the activation and differentiation of T cells. It is not part of a larger protein complex itself but interacts with other immune cell surface proteins for effective signaling. CD45RO is particularly important in the modulation of signal transduction through its phosphatase activity which removes phosphate groups from specific tyrosine residues on proteins influencing T cell sensitivity and response to antigens.

Pathways

CD45RO influences the JAK/STAT pathway a critical signaling pathway for cytokine receptor signaling in immune cells. It also plays a role in the TCR signaling pathway which is responsible for T cell activation. Within these pathways CD45RO acts in conjunction with other proteins like Lck and ZAP-70 that are also integral parts of T cell activation and proliferation processes essential for adaptive immune responses.

CD45RO is associated with autoimmune disorders such as rheumatoid arthritis where memory T cells play a role in sustaining inflammation. CD45RO also relates to chronic hepatitis B infection as it affects the disease progression through memory T cell-mediated immune responses. In these contexts CD45RO's interaction with other proteins like HLA-DR which is another immune-related surface protein becomes significant as it helps modulate immune responses that either suppress or exacerbate the disease symptoms.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor (PubMed : 35767951). Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity (By similarity). Interacts with CLEC10A at antigen presenting cell-T cell contact; CLEC10A on immature dendritic cells recognizes Tn antigen-carrying PTPRC/CD45 receptor on effector T cells and modulates T cell activation threshold to limit autoreactivity.. (Microbial infection) Acts as a receptor for human cytomegalovirus protein UL11 and mediates binding of UL11 to T-cells, leading to reduced induction of tyrosine phosphorylation of multiple signaling proteins upon T-cell receptor stimulation and impaired T-cell proliferation.
See full target information PTPRC

Publications (29)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:306 PubMed40240758

2025

Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics.

Applications

Unspecified application

Species

Unspecified reactive species

You-Xin Gao,Xiao-Jing Guo,Bin Lin,Xiao-Bo Huang,Ru-Hong Tu,Mi Lin,Long-Long Cao,Qi-Yue Chen,Jia-Bin Wang,Jian-Wei Xie,Ping Li,Chao-Hui Zheng,Ying-Hong Yang,Chang-Ming Huang,Jian-Xian Lin

Open biology 14:240060 PubMed39139050

2024

High-throughput functional analysis provides novel insight into type VII secretion in .

Applications

Unspecified application

Species

Unspecified reactive species

Yaping Yang,Aaron A Scott,Holger Kneuper,Felicity Alcock,Tracy Palmer

Theranostics 14:2915-2933 PubMed38773976

2024

Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Bin Wang,You-Xin Gao,Yin-Hua Ye,Qiao-Ling Zheng,Hua-You Luo,Shuan-Hu Wang,Tao Zhang,Qin-Wen Jin,Chao-Hui Zheng,Ping Li,Jian-Xian Lin,Qi-Yue Chen,Long-Long Cao,Ying-Hong Yang,Chang-Ming Huang,Jian-Wei Xie

Cancer biology & therapy 25:2333590 PubMed38532632

2024

M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yong Wang,Lisha Peng,Feng Wang

Cancer 130:1499-1512 PubMed38422056

2024

Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.

Applications

Unspecified application

Species

Unspecified reactive species

Xupeng Hou,Xueyang Li,Yunwei Han,Hua Xu,Yongjie Xie,Tianxing Zhou,Tongyuan Xue,Xiaolong Qian,Jiazhen Li,Hayson Chenyu Wang,Jingrui Yan,Xiaojing Guo,Ying Liu,Jing Liu

Nature communications 14:8438 PubMed38114483

2023

A type VII-secreted lipase toxin with reverse domain arrangement.

Applications

Unspecified application

Species

Unspecified reactive species

Stephen R Garrett,Nicole Mietrach,Justin Deme,Alina Bitzer,Yaping Yang,Fatima R Ulhuq,Dorothee Kretschmer,Simon Heilbronner,Terry K Smith,Susan M Lea,Tracy Palmer

Nature biotechnology 41:70-81 PubMed35953672

2022

Bioengineered corneal tissue for minimally invasive vision restoration in advanced keratoconus in two clinical cohorts.

Applications

Unspecified application

Species

Unspecified reactive species

Mehrdad Rafat,Mahmoud Jabbarvand,Namrata Sharma,Maria Xeroudaki,Shideh Tabe,Raha Omrani,Muthukumar Thangavelu,Anthony Mukwaya,Per Fagerholm,Anton Lennikov,Farshad Askarizadeh,Neil Lagali

American journal of cancer research 12:1752-1765 PubMed35530269

2022

Integrative immunogenomic analysis reveals transcriptional and immune-related differences in hepatocellular carcinoma patients with different disease-free survival.

Applications

Unspecified application

Species

Unspecified reactive species

Xueling Yang,Guanglin Lei,Junxiao Wang,Zhenyu Wen,Zhenhu Ma,Yun Zhao,Hui Ren,Hui Xie

Emerging microbes & infections 11:1191-1204 PubMed35317717

2022

Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jiapei Yu,Hui Li,Ju Jia,Zhisheng Huang,Shuai Liu,Ying Zheng,Shengrui Mu,Xiaoyan Deng,Xiaohui Zou,Yeming Wang,Xiao Shang,Dan Cui,Lixue Huang,Xiaoxuan Feng,William J Liu,Bin Cao

Cell reports. Medicine 2:100392 PubMed34622229

2021

Molecular predictors of response to pembrolizumab in thymic carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yongfeng He,Archana Ramesh,Yuriy Gusev,Krithika Bhuvaneshwar,Giuseppe Giaccone
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com